Arrowhead Pharmaceuticals (ARWR) Intangibles (2016 - 2025)
Historic Intangibles for Arrowhead Pharmaceuticals (ARWR) over the last 16 years, with Q4 2025 value amounting to $6.4 million.
- Arrowhead Pharmaceuticals' Intangibles fell 2090.45% to $6.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $6.4 million, marking a year-over-year decrease of 2090.45%. This contributed to the annual value of $6.9 million for FY2025, which is 1986.69% down from last year.
- According to the latest figures from Q4 2025, Arrowhead Pharmaceuticals' Intangibles is $6.4 million, which was down 2090.45% from $6.9 million recorded in Q3 2025.
- Arrowhead Pharmaceuticals' Intangibles' 5-year high stood at $14.5 million during Q1 2021, with a 5-year trough of $6.4 million in Q4 2025.
- In the last 5 years, Arrowhead Pharmaceuticals' Intangibles had a median value of $10.5 million in 2023 and averaged $10.5 million.
- In the last 5 years, Arrowhead Pharmaceuticals' Intangibles tumbled by 1048.74% in 2021 and then tumbled by 2090.45% in 2025.
- Arrowhead Pharmaceuticals' Intangibles (Quarter) stood at $13.2 million in 2021, then dropped by 12.85% to $11.5 million in 2022, then decreased by 14.74% to $9.8 million in 2023, then decreased by 17.28% to $8.1 million in 2024, then fell by 20.9% to $6.4 million in 2025.
- Its Intangibles stands at $6.4 million for Q4 2025, versus $6.9 million for Q3 2025 and $7.3 million for Q2 2025.